Local Control in Resectable and Borderline Resectable Pancreatic Cancer (PCa) Treated With Preoperative Chemoradiation or Chemotherapy Alone

被引：0
|
作者：
Kharofa, J. R. [1 ]
Kelly, T. [1 ]
George, B. [1 ]
Tsai, S. [1 ]
Ritch, P. [1 ]
Christians, K. [1 ]
Evans, D. [1 ]
Erickson, B. [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2013年 / 87卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2013.06.488
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S189 / S189
页数：1
相关论文
共 50 条
  • [31] Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer
    Mancini, Brandon R.
    Stein, Stacey
    Lloyd, Shane
    Rutter, Charles E.
    James, Edward
    Chang, Bryan W.
    Lacy, Jill
    Johung, Kimberly L.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (06) : 982 - 988
  • [32] Margin Status and Neoadjuvant Chemoradiation in Patients with Borderline Resectable Pancreatic Cancer
    Papavasiliou, P.
    Piposar, J. R.
    Arrangoiz, R.
    Chen, K. T.
    Zhu, F.
    Chun, Y.
    Hoffman, P.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S157 - S157
  • [33] Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer
    Jayme B. Stokes
    Norris J. Nolan
    Edward B. Stelow
    Dustin M. Walters
    Geoffrey R. Weiss
    Eduard E. de Lange
    Tyvin A. Rich
    Reid B. Adams
    Todd W. Bauer
    Annals of Surgical Oncology, 2011, 18 : 619 - 627
  • [34] Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic Cancer
    Kimura, Nana
    Yamada, Suguru
    Takami, Hideki
    Murotani, Kenta
    Yoshioka, Isaku
    Shibuya, Kazuto
    Sonohara, Fuminori
    Hoshino, Yui
    Hirano, Katsuhisa
    Watanabe, Toru
    Baba, Hayato
    Mori, Kosuke
    Miwa, Takeshi
    Kanda, Mitsuro
    Hayashi, Masamichi
    Matsui, Koshi
    Okumura, Tomoyuki
    Kodera, Yasuhiro
    Fujii, Tsutomu
    CANCERS, 2021, 13 (01) : 1 - 16
  • [35] Margin status and neoadjuvant chemoradiation in patients with borderline resectable pancreatic cancer
    Papavasiliou, Pavlos
    Piposar, Jonathan R.
    Arrangoiz, Rodrigo
    Chen, Kathryn T.
    Zhu, Fang
    Chun, Yun Shin
    Hoffman, John Parker
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [36] Is neoadjuvant chemoradiation important in borderline resectable pancreatic cancer (BRPC)? Clinical and surgical outcomes associated with preoperative FOLFIRINOX alone in BRPC.
    Kim, Sunhee S.
    Nakakura, Eric K.
    Wang, Zhen J.
    Kim, Grace E.
    Corvera, Carlos U.
    Harris, Hobart W.
    Kirkwood, Kimberly S.
    Hirose, Ryutaro
    Tempero, Margaret A.
    Ko, Andrew H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [37] Clinicopathological Investigation of Preoperative Chemotherapy for Resectable Pancreatic Cancer
    Tsuruta, Satoru
    Umehara, Yutaka
    Kimura, Akitoshi
    Murata, Akihiko
    Hakamada, Kenichi
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S291 - S291
  • [38] Maximizing the Effect of Neoadjuvant Chemoradiation in Patients with Borderline Resectable Pancreatic Cancer
    Sopka, D. M.
    Chun, Y. S.
    Cohen, S. J.
    Zhu, F.
    Milestone, B. N.
    Cooper, H. S.
    Freedman, G. M.
    Burtness, B. A.
    Hoffman, J. P.
    Meyer, J. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S335 - S335
  • [39] Extended neoadjuvant chemotherapy (CT) in borderline resectable pancreas cancer (BRPC): Is preoperative chemoradiation (CRT) essential?
    Picozzi, Vincent J.
    Rocha, Flavio G.
    Rose, J. Bart
    Traverso, L. William
    Alseidi, Adnan
    Lin, Bruce S.
    Biehl, Thomas A.
    Ryan, John A.
    Moonka, Ravi
    Helton, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [40] Neoadjuvant Chemoradiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma
    Shafi, S.
    Kaubisch, A.
    PANCREAS, 2015, 44 (08) : 1413 - 1413
12345